Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein

Neurology

Volumn 51, Issue 3, 1998, Pages 887-889

  Arawaka, S ^c   Saito, Y ^a   Murayama, S ^a   Mori, H ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CASE REPORT; CLINICAL FEATURE; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LEWY BODY; NERVE DEGENERATION; ONSET AGE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0031721278     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.3.887     Document Type: Article

References (10)

1. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993;52:183-191.
2. Trojanowski JQ, Lee VM-Y. Aggregation of neurofilament and α-synuclein proteins in Lewy bodies. Arch Neurol 1998;55:151-152.
3. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y. Lewy bodies are ubiquitinated: a light and electron microscopic immunocytochemical study. Acta Neuropathol 1988;75: 345-353.
4. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
5. Spillantini MG, Schmidt ML, Lee VM-Y, et al. α-Synuclein in Lewy bodies. Nature 1997;388:839-840.
6. Taylor TD, Litt M, Kramer P, et al. Homozygosity mapping of Hallervoprden-Spatz syndrome to chromosome 20p12.3-p13. Nature Genet 1996;14:479-481.
7. Ueda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-11286.
8. Kruger R, Kuhn W, Mller T, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genet 1998;18:106-108.
9. Munoz E, Oliva R, Obach V, et al. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the α-synuclein gene in early onset patients. Neurosci Lett 1997;235:57-60.
10. Zareparsi S, Kay J, Camicioli R, et al. Analysis of the α-synuclein G209A mutation in familial Parkinson's disease. Lancet 1998;351:37-38.